hrcak mascot   Srce   HID

Izvorni znanstveni članak
https://doi.org/10.2478/v10007-010-0036-5

Aceclofenac topical dosage forms: In vitro and in vivo characterization

KAMAL DUA ; Department of Pharmaceutical Technology, School of Pharmacy and Allied Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia-57000
KAVITA PABREJA ; Department of Life Sciences, School of Pharmacy and Allied Health Sciences, International Medical University, Kuala Lumpur, Malaysia-57000
MALIPEDDI VENKATA RAMANA ; VIT University, Vellore, Tamilnadu-632014, India

Puni tekst: engleski, pdf (171 KB) str. 467-478 preuzimanja: 1.469* citiraj
APA 6th Edition
DUA, K., PABREJA, K. i RAMANA, M.V. (2010). Aceclofenac topical dosage forms: In vitro and in vivo characterization. Acta Pharmaceutica, 60 (4), 467-478. https://doi.org/10.2478/v10007-010-0036-5
MLA 8th Edition
DUA, KAMAL, et al. "Aceclofenac topical dosage forms: In vitro and in vivo characterization." Acta Pharmaceutica, vol. 60, br. 4, 2010, str. 467-478. https://doi.org/10.2478/v10007-010-0036-5. Citirano 24.08.2019.
Chicago 17th Edition
DUA, KAMAL, KAVITA PABREJA i MALIPEDDI VENKATA RAMANA. "Aceclofenac topical dosage forms: In vitro and in vivo characterization." Acta Pharmaceutica 60, br. 4 (2010): 467-478. https://doi.org/10.2478/v10007-010-0036-5
Harvard
DUA, K., PABREJA, K., i RAMANA, M.V. (2010). 'Aceclofenac topical dosage forms: In vitro and in vivo characterization', Acta Pharmaceutica, 60(4), str. 467-478. https://doi.org/10.2478/v10007-010-0036-5
Vancouver
DUA K, PABREJA K, RAMANA MV. Aceclofenac topical dosage forms: In vitro and in vivo characterization. Acta Pharm. [Internet]. 2010 [pristupljeno 24.08.2019.];60(4):467-478. https://doi.org/10.2478/v10007-010-0036-5
IEEE
K. DUA, K. PABREJA i M.V. RAMANA, "Aceclofenac topical dosage forms: In vitro and in vivo characterization", Acta Pharmaceutica, vol.60, br. 4, str. 467-478, 2010. [Online]. https://doi.org/10.2478/v10007-010-0036-5

Sažetak
Aceclofenac is a new generation non-steroidal anti-inflammatory drug showing effective anti-inflammatory and analgesic properties. It is available in the form of tablets of 100 mg. Importance of aceclofenac as a NSAID has inspired development of topical dosage forms. This mode of administration may help avoid typical side effects associated with oral administration of NSAIDs, which have led to its withdrawal. Furthermore, aceclofenac topical dosage forms can be used as a supplement to oral therapy for better treatment of conditions such as arthritis. Ointments, creams, and gels containing 1 % m/m aceclofenac have been prepared. They were tested for physical appearance, pH, spreadability, extrudability, drug content uniformity, in vitro diffusion and in vitro permeation. Gels prepared using Carbopol 940 (AF2, AF3) and macrogol bases (AF7) were selected after the analysis of the results. They were evaluated for acute skin irritancy, anti-inflammatory and analgesic effects using the carrageenan-induced thermal hyperalgesia and paw edema method. AF2 was shown to be significantly (p < 0.05) more effective in inhibiting hyperalgesia associated with inflammation, compared to AF3 and AF7. Hence, AF2 may be suggested as an alternative to oral preparations.

Ključne riječi
aceclofenac; topical gel; in vitro activity; in vivo activity

Hrčak ID: 59504

URI
https://hrcak.srce.hr/59504

[hrvatski]

Posjeta: 1.949 *